Epidemiology and Prognosis of Pheochromocytoma/Paraganglioma in Korea: A Nationwide Study Based on the National Health Insurance Service

BackgroundPheochromocytomas and paragangliomas (PPGLs) are rare endocrine tumors originating from chromaffin cells. PPGLs are associated with a high mortality rate and several complications. To date, no epidemiological studies have been conducted on PPGLs in Asia. This study aimed to investigate the...

Full description

Bibliographic Details
Main Authors: Jung Hee Kim, Hyemi Moon, Junghyun Noh, Juneyoung Lee, Sin Gon Kim
Format: Article
Language:English
Published: Korean Endocrine Society 2020-03-01
Series:Endocrinology and Metabolism
Subjects:
Online Access:https://e-enm.org/Synapse/Data/PDFData/2008ENM/enm-35-157.pdf
_version_ 1818353186434449408
author Jung Hee Kim
Hyemi Moon
Junghyun Noh
Juneyoung Lee
Sin Gon Kim
author_facet Jung Hee Kim
Hyemi Moon
Junghyun Noh
Juneyoung Lee
Sin Gon Kim
author_sort Jung Hee Kim
collection DOAJ
description BackgroundPheochromocytomas and paragangliomas (PPGLs) are rare endocrine tumors originating from chromaffin cells. PPGLs are associated with a high mortality rate and several complications. To date, no epidemiological studies have been conducted on PPGLs in Asia. This study aimed to investigate the epidemiology and prognosis of PPGLs in Korea using nationwide data.MethodsUsing the National Health Insurance Service Database, subjects with a principal diagnosis of PPGLs on two or more occasions between 2003 and 2014 who satisfied the operational definition of PPGLs were included. Incidence, prevalence, complications, metastasis, and mortality were investigated.ResultsIn total, 1048 subjects with a mean age of 47.6±16.1 years were included. There was no sex preponderance. The overall prevalence of PPGLs was 2.13 per 100,000 persons, and the overall age-standardized incidence rate was 0.18 per 100,000 person-years. Malignant PPGLs accounted for 17.7% (185 of 1,048) of cases, and 94 subjects exhibited metastasis at the time of diagnosis. Among initially non-metastatic PPGLs, 9.5% (nine of 954) eventually metastasized after a mean duration of 78.1±41.4 months. The 5-year survival rates for non-metastatic and metastatic PPGLs at diagnosis were 97% and 84%, respectively. Multivariable Cox regression models adjusted for covariates showed that metastatic PPGLs were associated with a 2.40-fold higher risk of mortality than non-metastatic PPGLs (95% confidence interval, 1.38 to 4.17; P=0.002).ConclusionPPGLs are rare in Korea, and the prognosis of these endocrine tumors varies depending on whether they are benign or malignant. This epidemiological study paves the way for further research on PPGLs.
first_indexed 2024-12-13T19:05:32Z
format Article
id doaj.art-bea5ac2559ef4995b63385088f4ff702
institution Directory Open Access Journal
issn 2093-596X
2093-5978
language English
last_indexed 2024-12-13T19:05:32Z
publishDate 2020-03-01
publisher Korean Endocrine Society
record_format Article
series Endocrinology and Metabolism
spelling doaj.art-bea5ac2559ef4995b63385088f4ff7022022-12-21T23:34:33ZengKorean Endocrine SocietyEndocrinology and Metabolism2093-596X2093-59782020-03-0135115716410.3803/EnM.2020.35.1.157Epidemiology and Prognosis of Pheochromocytoma/Paraganglioma in Korea: A Nationwide Study Based on the National Health Insurance ServiceJung Hee Kim0Hyemi Moon1Junghyun Noh2Juneyoung Lee3Sin Gon Kim4Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, .KoreaDepartment of Biostatistics, Korea University College of Medicine, Seoul, .KoreaDivision of Endocrinology and Metabolism, Department of Internal Medicine, Inje University Ilsan Paik Hospital, Inje University College of Medicine, Goyang, .KoreaDepartment of Biostatistics, Korea University College of Medicine, Seoul, .KoreaDivision of Endocrinology and Metabolism, Department of Internal Medicine, Korea University College of Medicine, Seoul, .KoreaBackgroundPheochromocytomas and paragangliomas (PPGLs) are rare endocrine tumors originating from chromaffin cells. PPGLs are associated with a high mortality rate and several complications. To date, no epidemiological studies have been conducted on PPGLs in Asia. This study aimed to investigate the epidemiology and prognosis of PPGLs in Korea using nationwide data.MethodsUsing the National Health Insurance Service Database, subjects with a principal diagnosis of PPGLs on two or more occasions between 2003 and 2014 who satisfied the operational definition of PPGLs were included. Incidence, prevalence, complications, metastasis, and mortality were investigated.ResultsIn total, 1048 subjects with a mean age of 47.6±16.1 years were included. There was no sex preponderance. The overall prevalence of PPGLs was 2.13 per 100,000 persons, and the overall age-standardized incidence rate was 0.18 per 100,000 person-years. Malignant PPGLs accounted for 17.7% (185 of 1,048) of cases, and 94 subjects exhibited metastasis at the time of diagnosis. Among initially non-metastatic PPGLs, 9.5% (nine of 954) eventually metastasized after a mean duration of 78.1±41.4 months. The 5-year survival rates for non-metastatic and metastatic PPGLs at diagnosis were 97% and 84%, respectively. Multivariable Cox regression models adjusted for covariates showed that metastatic PPGLs were associated with a 2.40-fold higher risk of mortality than non-metastatic PPGLs (95% confidence interval, 1.38 to 4.17; P=0.002).ConclusionPPGLs are rare in Korea, and the prognosis of these endocrine tumors varies depending on whether they are benign or malignant. This epidemiological study paves the way for further research on PPGLs.https://e-enm.org/Synapse/Data/PDFData/2008ENM/enm-35-157.pdfpheochromocytomaparagangliomaepidemiologyprevalenceincidenceprognosismortality
spellingShingle Jung Hee Kim
Hyemi Moon
Junghyun Noh
Juneyoung Lee
Sin Gon Kim
Epidemiology and Prognosis of Pheochromocytoma/Paraganglioma in Korea: A Nationwide Study Based on the National Health Insurance Service
Endocrinology and Metabolism
pheochromocytoma
paraganglioma
epidemiology
prevalence
incidence
prognosis
mortality
title Epidemiology and Prognosis of Pheochromocytoma/Paraganglioma in Korea: A Nationwide Study Based on the National Health Insurance Service
title_full Epidemiology and Prognosis of Pheochromocytoma/Paraganglioma in Korea: A Nationwide Study Based on the National Health Insurance Service
title_fullStr Epidemiology and Prognosis of Pheochromocytoma/Paraganglioma in Korea: A Nationwide Study Based on the National Health Insurance Service
title_full_unstemmed Epidemiology and Prognosis of Pheochromocytoma/Paraganglioma in Korea: A Nationwide Study Based on the National Health Insurance Service
title_short Epidemiology and Prognosis of Pheochromocytoma/Paraganglioma in Korea: A Nationwide Study Based on the National Health Insurance Service
title_sort epidemiology and prognosis of pheochromocytoma paraganglioma in korea a nationwide study based on the national health insurance service
topic pheochromocytoma
paraganglioma
epidemiology
prevalence
incidence
prognosis
mortality
url https://e-enm.org/Synapse/Data/PDFData/2008ENM/enm-35-157.pdf
work_keys_str_mv AT jungheekim epidemiologyandprognosisofpheochromocytomaparagangliomainkoreaanationwidestudybasedonthenationalhealthinsuranceservice
AT hyemimoon epidemiologyandprognosisofpheochromocytomaparagangliomainkoreaanationwidestudybasedonthenationalhealthinsuranceservice
AT junghyunnoh epidemiologyandprognosisofpheochromocytomaparagangliomainkoreaanationwidestudybasedonthenationalhealthinsuranceservice
AT juneyounglee epidemiologyandprognosisofpheochromocytomaparagangliomainkoreaanationwidestudybasedonthenationalhealthinsuranceservice
AT singonkim epidemiologyandprognosisofpheochromocytomaparagangliomainkoreaanationwidestudybasedonthenationalhealthinsuranceservice